Archive for the ‘Treatment’ Category

ACTION ALERT: FDA Trying to Ban CBD

https://www.paintreatmentdirectory.com/posts/the-fda-is-trying-to-ban-cbd-supplements

The FDA is Trying to Ban CBD Supplements

The FDA is Trying to Ban CBD Supplements

By: ANH-USA

Editor’s note: The following article and call to action about the FDA’s efforts to ban CBD supplements is being reprinted from the Alliance for Natural Health website. This is not the first time the FDA has tried banning natural treatments relied on by millions of Americans, but part of a long and corrupt history. The FDA has also been trying for several years to ban kratom, an herb being successfully used by millions of Americans to treat pain, opioid addiction and withdrawal, anxiety and more. Recently, the FDA has also taken action against homeopathy, a safe, natural system of medicine used worldwide since its development in 1810. The FDA has been trying to get stronger regulatory authority to take vitamins and other supplements off the market. It seems the FDA is leaving no stone unturned in its efforts to protect the profits of the pharmaceutical industry instead of protecting the health of the public.

The FDA Misleads on CBD Safety

…providing further evidence that the agency is trying to engineer a ban on affordable CBD to protect drug industry profits. Action Alert!

As the evidence of CBD’s myriad health benefits continues to pile up, it increasingly looks to us like the FDA is preparing to issue a ban on CBD supplements. We must support bills in Congress that take the issue out of the FDA’s hands by allowing the sale of CBD in supplement form.

Lawmakers do appear to be taking this issue seriously. In addition to the bill introduced by Representative Morgan Griffith (R-VA), another similar bill has just been introduced by Senators Ron Wyden (D-OR), Rand Paul (R-KY), Jeff Merkley (D-OR), and Representative Earl Blumenauer (D-OR) to allow the sale of CBD in supplements. Additionally, Congress is holding a hearing on July 27 during which members will formally scrutinize the impact of the FDA’s failure to develop a regulatory pathway for the sale of CBD in supplements and food. Let’s show the FDA the scale of our opposition to its unjustified plan and demonstrate the huge level of grassroots support for CBD supplements ahead of the hearing.

We want to make it crystal clear what we face if we don’t stop the FDA in its tracks. CBD, or cannabidiol, is one of over 100 natural compounds called cannabinoids found in a wide range of plants, most notably the hemp plant. The cells of our bodies are laced with cannabinoid receptors that form part of the endocannabinoid system that is essential to life and to robust health. We produce cannabinoids internally (endocannabinoids) and we also consume them in some foods (exocannabinoids). Most of these cannabinoids, including CBD, are not psychoactive – THC being an exception – but they all offer profound benefits. CBD is one of the most well researched non-psychoactive cannabinoids and it has an incredible array of health benefits, with evidence showing that has profound anti-inflammatory and immune modulating effects and can help with pain, anxiety, depression, certain cancers, and even heart health.

Let that sink in for a moment. The opioid epidemic is killing an astonishing number of Americans every year; rates of anxiety and depression are reaching new highs, particularly among young people; heart disease is the leading cause of death for adults in the US. CBD has been found to help with all of these conditions, but instead of working to make this compound more widely available as a supplement, which is the way it should be sold according to the Dietary Supplement and Health Education Act of 1994 (DSHEA), the FDA wants to stop all supplement sales of CBD. The FDA’s justification is the protection of the profits of one pharmaceutical company that has a CBD drug that will cost patients a stunning $32,500 per year. It will also mean citizens who have been benefiting from low-cost health support from CBD supplements since they became widely available a few years ago will have no further access to the supplements they have relied on. There is something deeply wrong with this picture.

How did we get here? For starters, the FDA says that CBD can’t be a supplement because it has approved a drug version of CBD called Epidiolex that is used to treat two rare forms of epileptic seizure, Lennox-Gastaut syndrome (LGS) or Dravet syndrome, in children over 2 years. This ability for FDA to rule in favor of drug companies has to do with the FDA back-channel that we’ve written about many times before. In short, if a substance is studied as a drug (i.e. a drug company has made an Investigational New Drug application) before there is evidence it was sold as a supplement (i.e. evidenced by a supplement company’s New Dietary Ingredient notification), then the drug company can ask the FDA to ban the supplement form of that compound.

Yet, as pressure mounts from Congress and a variety of stakeholders to make CBD more widely available, the FDA has been reviewing scientific information on CBD. Earlier this year, the agency released a statement explaining that the “existing regulatory framework” for foods and supplements is not appropriate for CBD and that a new regulatory pathway is needed.

One of the main issues raised by the FDA is that of safety. The agency claims that CBD presents various safety concerns, specifically the potential for harm to the liver and the reproductive system and concerns for vulnerable populations such as children and pregnant women.

These views are articulated in a review article authored in part by FDA staff. To support the assertion that CBD can pose threats to the male reproductive system, the authors cite a 1981 animal study in which monkeys were administered 30, 100, or 300 milligrams per kilogram of body weight per day (mg per kg bw/day) of CBD orally. But consider that 300 mg per kg bw/day for a human weighing 154 pounds would be 21,000 mg, or 21g, of CBD—far, far more than anyone would ever take as a supplement!

This is emblematic of a larger problem we’ve discussed before: the deeply flawed risk assessment models used by federal bureaucrats to prevent us from utilizing natural medicines to stay healthy. These types of models have been used by European regulators to set absurd limits on supplement dosages (known as tolerable upper limits, or ULs). ANH’s founder and Executive and Scientific Director, Robert Verkerk, PhD, has published several papers critiquing this approach that was originally developed by the Institute of Medicine (now the National Academy of Medicine), pointing to a fundamental flaw: in trying to restrict vitamin or other micronutrient dosages in this way, regulators completely ignore the fact that risks vary greatly depending on the form and dose of a nutrient used, and for most populations you’ll find overlap in the doses that cause health benefits for the majority and risks for a few. So if you then create a law that aims to eliminate a potential risk for everyone, you actually deprive the vast majority access to the micronutrient and all the benefits it offers.

Bringing it back to CBD: the fact that the FDA is, in part, using a decades-old animal study in which an absurdly high CBD dose was used to demonstrate that CBD has safety concerns once again demonstrates that the federal approach to assessing risk and benefit is fundamentally broken. It’s based on a defunct toxicological model that should have no place in modern day food or supplement law-making. The agency is also not giving proper weight to the incredibly favorable safety record of CBD used as a supplement or the multitude of benefits we can get from using CBD as a supplement. Instead, the FDA has chosen to focus on old evidence of harm that was only found when absurdly high doses were taken experimentally. To us, it seems like the agency is simply grasping at any information it can to demonstrate harm so it can justify its proposed ban on CBD supplements. The driver? Nothing less than preventing competition for the pharmaceutical drug version of CBD, given its the drug companies that are the FDA’s principal paymasters.

And, indeed, the FDA’s view on CBD’s safety is not supported by experts in the industry and elsewhere. A 2020 meta-analysis looked at human trials to assess CBD efficacy and safety. The authors concluded that most studies reported no adverse events with acute administration of CBD and mild to moderate effects with chronic administration, with the most common side effects being tiredness, diarrhea and changes of appetite/weight. Again, these side effects must be weighed against the benefits of CBD use for combatting opioid misuse, heart disease, anxiety, and depression. Harvard Health Publishing, the publication of the Harvard Medical School, states simply that, for adults, “CBD appears to be very safe.”

We cannot allow the FDA to cater to the drug industry at the expense of public health.

Action Alert! Write to Congress in support of bills that allow the legal sale of CBD in supplements. Please send your message immediately.

The FDA has said that they will not be allowing CBD to be in food or supplements, explaining that the “existing regulatory framework” for foods and supplements are not appropriate for CBD. The agency denied three Citizens Petitions requesting the agency issue a regulation that would allow CBD to be sold as a supplement. Clearly the FDA is more interested in protecting Big Pharma profits than with promoting consumer access to a product that can benefit their health. We need Congress to take the issue out of the FDA’s hands to create a legal pathway for CBD supplements.

Write to Congress and tell them to support the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 and the Hemp Access and Consumer Safety Act to protect access to CBD supplements.

Sign the Petition Here

_________________

**Comment**

The FDA wants patients between a rock and a hard place.  On one hand they state extended antibiotics are not to be used for Lyme/MSIDS because they are unsafe, and then they also want to remove important supplements that help us, but when the agency is alerted to the fact doctors have never witnessed so many “vaccine”-related injuries and VAERS reports are higher than any other vaccine in its history, after the mRNA gene therapy injections……crickets.

Something doesn’t smell right.

If the FDA had their way we’d just all die already.

For more:

The FDA has a long & sordid history of attempting to ban anything it views as competition to its lucrative drugs & vaccines due to its vested interests with Big Pharma.

Category:

Activism, Herbs, Inflammation, Pain Management, Sleep, Supplements, Treatment

The Lyme Puzzle: Interview With Professor Nicole Baumgarth

https://podcast.tickbootcamp.com/episode/8bc4afa1/the-lyme-puzzle-an-interview-with-professor-nicole-baumgarth

Episode 364: The Lyme Puzzle – an interview with Professor Nicole Baumgarth

July, 2023

Introduction

  • In this episode of Tick Boot Camp, our hosts Matt Sabatello and Rich Johannesen had the opportunity to talk with the remarkable Professor Nicole Baumgarth, director of the Lyme and Tick-Borne Diseases Institute at Johns Hopkins University. Baumgarth brings a unique interdisciplinary background in veterinary medicine, immunology, microbiology, and pathology offering fresh insights into the complex world of Lyme disease and tick-borne illnesses.

Lyme Disease Research

  • Baumgarth and her team are investigating why we don’t mount an effective adaptive immune response to Lyme as we do with influenza (the flu).
  • She reveals their interesting finding about how Borrelia may alter the host’s gut microbiome to enhance its survival.
  • Baumgarth and her team are currently investigating why macrophages, immune cells that gobble up pathogens outside of our cells, don’t eat up Lyme bacteria as they do with other bacteria and viruses.
  • They are also investigating the impact Lyme has on obliterating our lymph nodes, which are critical agents in receiving signals from our body and mounting a specified immune response with targeted B cells and T cells against things like Lyme disease, as well as deploying long term memory immune cells and plasma cells which would give us long-term immunity to Lyme.
  • The Lyme and Tick-Borne Diseases Institute is focusing on investigating why mice get infected with Lyme, the infection persists, yet they never get sick from the infection.
  • If the team can identify human immune system deficits causing any of the above, they could identify immune therapies to overcome these shortcomings and treat all stages of Lyme disease.
  • Baumgarth and her team are also looking into the impact of tick-borne co-infections. They argue that it’s critical to study these diseases together rather than in isolation.

Autoimmune Responses and Lyme Disease

  • Professor Baumgarth suggests that Lyme disease may cause an autoimmune response, which can be particularly concerning for those with genetic predispositions to autoimmunity.
  • She cites several studies, both in the human model and mouse model, proving that Lyme disease creates an unnecessary increase in other antibodies from our immune system that aren’t Lyme-related, resulting in an autoimmunity phenomenon, increased inflammation, and potential immune system burnout.

Understanding Lyme Disease: A Veterinary Perspective

  • Professor Baumgarth’s veterinary background has allowed her to approach Lyme disease from a macro perspective. She emphasizes that Lyme, being a zoonotic disease, is fundamentally an infection that moves from animals to humans.
  • Lyme disease is often a natural infection in animals such as small rodents and birds, where ticks can bite them and transmit the disease.

Investigating the Human Immune Response to Lyme Disease

  • Our hosts discuss how humans’ immune responses to Lyme vary significantly. Some people are bitten by ticks multiple times without falling ill, while others suffer from chronic Lyme after just one bite.
  • This discrepancy might be due to factors such as genetic predispositions, environmental stresses, or an individual’s microbial load.

The Complexity of Eradicating Lyme

  • Eliminating Lyme is not as simple as wiping out a certain animal species, as the bacteria Borrelia can infect a variety of different rodents and even birds.
  • Borrelia is a complex bacterium that replicates slowly and requires a tick to infect a host. It’s constantly evolving and it’s not a simple task to eradicate Lyme from our ecology.

The Role of Antibiotics and Their Impact

  • Despite their potential long-term impact on our immune response, antibiotics are currently the most common form of treatment as soon as Lyme disease is diagnosed. Professor Baumgarth emphasizes a variety of risks when using antibiotics to treat Lyme disease.
  • While antibiotics can help in the short term, their effect on our long-term immunity to future infections is still unclear and Professor Baumgarth strongly warns against prolonged use of antibiotics.

Final Thoughts

  • Baumgarth is hopeful about the future of Lyme disease research. Despite the challenges and controversies, she believes that continued progress is possible with dedicated research and interdisciplinary collaboration.

Episode Wrap-up

  • Professor Nicole Baumgarth’s interview provides an enlightening look into the intricate world of Lyme disease and its complex interaction with our immune system. Her unique veterinary perspective coupled with her background in immunology, microbiology, and pathology as well as her research findings shed light on the challenges we face and offer hope for future breakthroughs in the fight against Lyme and tick-borne diseases.

__________________

**Comment**

My husband and I probably would not be on planet earth without long-term antibiotics so I’m glad this researcher didn’t treat us.  She’s just touting the safe narrative that is expected of academics working in research institutions that get their bread and butter from government grants with many strings attached, controlled by agencies that are completely corrupt.

Nobody denies the risk of prolonged use of antibiotics; however, Lyme/MSIDS can kill you in a myriad of ways.  This never seems to be discussed in the same sentence as prolonged antibiotics.  We would all love a safe, effective, affordable treatment.  Why aren’t researchers looking into this?  I’ll answer you: there’s no money in it, and it doesn’t fit with their narrative for a lucrative cash cow in a Lyme “vaccine.”  

It’s easy to be an arm-chair quarterback when it isn’t your neck on the chopping block.  All I can say is, whatever your opinions are about antibiotics before contracting Lyme/MSIDS, I guarantee they will change as you trod this pot-holed riddled, devastating path.  I hadn’t used antibiotics for 20 years before becoming infected.  I would use ANYTHING but antibiotics.  After I got infected I literally bathed in them for years.  I’m not proud of this, but they worked for both my husband and I, and many others.

It takes savvy to treat this complex illness and while anti-microbials are a MUST, there are many other important treatments required.  Please see the first link below for many treatments that experienced LLMDs have used with success.

For more:

Category:

Lyme, research, Treatment

Chronic Lyme Disease Patients Want to Be Treated, Not “Managed” By Physicians

https://danielcameronmd.com/recommendations-to-clinicians-on-how-to-handle-chronic-lyme-disease-patients/

CHRONIC LYME DISEASE PATIENTS WANT TO BE TREATED, NOT ‘MANAGED’ BY PHYSICIANS

Over the past month, a series of articles, focusing on multiple aspects of Lyme disease, from pediatric Lyme to chronic Lyme to life after Lyme, have been published in the May and June issues of Infectious Disease Clinics of North America and Clinical Infectious Diseases. The articles echo messages that, for the most part, minimize a disease that impacts hundreds of thousands of people each year — many of whom are children.

By 

“Minds are like parachutes. They only function when open.” This particular quote by Thomas Dewar came to mind after reading an article, Chronic Lyme Disease (1) in the June issue of Infectious Disease Clinics of North America.

In it, the author writes, “the scientific community has largely rejected chronic, treatment-refractory Borrelia burgdorferi infection.” This is based on “the failure to detect cultivatable, clinically relevant organisms after standard treatment.”

The intention of the Chronic Lyme Disease article is evident — convince readers that chronic Lyme disease does not exist, and that antibiotics prescribed for more than 14- to 28-days are of no benefit and most patients have no lingering symptoms.

It is particularly troublesome that the author, Paul Lantos, MD, a Duke University Medical Center researcher, is co-chair on a panel responsible for updating the Infectious Disease Society of America’s (IDSA) treatment guidelines for Lyme disease. Dr. Lantos holds a position not to be taken lightly. The IDSA recommendations will determine, for the most part, the types of treatment patients diagnosed with Lyme disease will receive.

Additionally, Dr. Lantos includes a section entitled, “Clinical Approach to Patients with Chronic Lyme Disease Diagnosis,” in which he offers suggestions to physicians on how to ‘manage’ patients complaining they have chronic Lyme disease. Recommendations include listening patiently during the consultation and then explaining to the patient why their symptoms are not related to Lyme disease.

“…a certain amount of time must be spent reviewing past experiences and past laboratory tests … then explaining why Lyme disease may not account for their illnesses.”

“Even if chronic Lyme disease lacks biological legitimacy, its importance as a phenomenon can be monumental to the individual patient,” says Lantos. “Many have undergone frustrating, expensive, and ultimately fruitless medical evaluations. And many have become quite disaffected with a medical system that has failed to provide answers.”

Managing patients, who insist they have chronic Lyme disease can be challenging, he warns. This subset of patients can have “great variation in their ‘commitment’ to a chronic Lyme disease diagnosis. Some patients are entirely convinced they have chronic Lyme disease, they request specific types of therapy, and they are not interested in adjudicating the chronic Lyme disease diagnosis.”

Should a clinician have a patient who believes they have chronic Lyme disease, there are several ways to manage the evaluation, he explains. First, “the physician needs to suppress preconceptions or biases about such patients.”

Second, “the process of clinical information gathering in medicine … is no different in the context of chronic Lyme disease. Even if much discussion is centered on chronic Lyme disease.”

And, lastly, “it is of utmost importance to not seem to be impatient, dismissive, or rushed. Many patients who seek care for chronic Lyme disease already have accumulated frustration. … Each patient’s clinical story and personal history is unique and valid, even if one concludes that they do not have Lyme disease.”

For the patients who do remain chronically symptomatic, Dr. Lantos explains, there has been “little evidence of active infection, and their symptoms do not respond to antibiotics any better than to placebo.”

When dealing with complex, chronic illnesses, physicians need to develop a trusting and understanding relationship with their patients. It is impossible for a clinician to provide the highest level of care to their patients, which includes a thorough evaluation, if they enter into the doctor-patient relationship with preconceived notions, not only about an extremely complex disease but about the patient who is reporting the symptoms, which are often subjective.

Should the patient not have any of the three objective signs of Lyme disease — the bulls-eye rash, swollen knee and/or Bell’s Palsy, identifying the infection is dependent on a strong evaluation. Patients want physicians to provide effective treatments. They don’t want to be ‘managed.’

It is time for a new narrative. One that recognizes the complexity of the Lyme spirochete and acknowledges the ineffective simplicity of the ‘one-size fits all’ treatment approach.

References:

  1. Lantos PM. Chronic Lyme Disease. Infect Dis Clin North Am, 29(2), 325-340 (2015).

___________________

**Comment**

Lantos is obviously unaware of this which showed a 70% complete remission of symptoms:   https://madisonarealymesupportgroup.com/2023/07/24/paralyzed-by-lyme-they-were-helped-with-combo-treatments/

Also, it’s imperative to point out that coinfections are rarely taken into consideration, yet chronically infected patients are notoriously coinfected with other pathogens.  The fact they don’t improve is most probably due to the fact they are not treating these coinfections which can be as bad if not worse than Lyme.  Bartonella and Babesia are two such pathogens that can knock you off your feet but require very different medications than Lyme meds.  This is simply never discussed.

My husband and I are two chronically infected patients that have improved vastly with extended antimicrobial treatment.  Without this treatment, I’m not sure either of us would be alive.  I know many others in this boat as well.  We don’t make the research papers because none of us fit the criteria to even enter a study:

These parameters that continue to be used will continue to give a preconceived outcome: no chronic/persistent infection.  It’s circular reasoning of the worst kind that hasn’t budged in over 40 years.

Compare this to Dr. Lee Merritt’s informative talk where she describes experiments done on prisoners in the 1900’s that would see them deliberately infected with the Spanish Flu.

The experiments would see some of the prisoners injected with infected lung tissue from sick or deceased patients, have infected tissue dropped in their eyes, and sprayed in the nose and mouth with infectious aerosols. Others would see mucus taken from critically ill patients and put it into the noses and throats of prisoners. In other parts of the trials, experimenters would take the blood of the sick and inject it into the healthy, to see if it was spread through infectious microorganisms in the blood.

As well as the various fluid exchanges mentioned above, a further part of the experiments saw ten healthy prisoners taken into a hospital for patients who were dying of the disease. There, they were asked to stand over the sick and dying, lean over their faces and breathe in heavily while they exhaled. Just to be sure of exposure, the flu patients would cough into the face and mouths of the prisoners.

Guess what?  Not a single patient in the experiment died of the disease – they didn’t even become ill. 
Ponder this for a moment.  
I mean, what is the likelihood?
Yet, despite this fact, we are told that the Spanish Flu is the most deadly virus on the planet.
According to many experts, this lack of proof of viral infectivity is a big deal but has resulted in a massively lucrative “vaccination” program that only worsens with time – now forcing people to concede to these injections or lose their jobs.
Meanwhile, back in Lymeland, lack of definitive proof stops the show.  Experts claim, “If we can’t see it, smell it, touch it, it doesn’t exist.” 
Anyone with half a brain would see this comparison and acknowledge that something is truly rotten in Denmark.

******

Category:

Activism, Lyme, research, Testing, Treatment, vaccines, Viruses

Genetics & Susceptibility to COVID

**UPDATE**

All of this was written about back in March when it was discovered that China has been purchasing the DNA of Americans. China’s BGI – a large manufacturer of one of the most popular prenatal tests in the world developed with the military, has been harvesting data from millions of women, and analyzing the data with AI.  So far 8 million women have taken BGI’s prenatal tests globally. One BGI study used a military supercomputer to re-analyze data and map the prevalence of viruses in Chinese women, look for indicators of mental illness in them, and single out Tibetan and Uyghur minorities to find links between their genes and their characteristics.

But wait, there’s more.
  • 60 Minutes learned that BGI offered to build COVID testing labs in at least six states and Chinese companies are investing in biotech companies which gives them access to health data.
  • Reuters reported that BGI, partnering with the PLA, share a dozen patents for DNA tests and one 2015 patent is for a “low-cost kit to detect respiratory pathogens, including SARS (Sever Respiratory Syndrome) and coronaviruses. 
  • BGI’s chief infectious disease expert is listed as an inventor on the patent while also being one of the 1st scientists to have sequenced COVID-19 samples from a Wuhan military hospital.
  • BGI, worth a market value of around $9 million and known for creating a cloned pig, has sold millions of their COVID-19 test kits around the world.
This should frighten everyone, but particularly immunocompromised Lyme/MSIDS patients as many of them get genetic testing done to try and help them fine-tune their treatment.

In April, 2021 this website posted an article showing that a relationship between the Gates Foundation and BGI goes back nearly a decade, with the Gates Foundation actually funding BGI projects relating to genome sequencing. The former president of the Bill & Melinda Gates Foundation’s global health program, serves as the Chairman of BGI’s Scientific Advisory Board.

One American genetic testing company widely used by Lyme/MSIDS patients called 23andme announced it would become a publicly traded company with the help of billionaire Richard Branson. A spider-web exists which includes Branson, Jeffrey Epstein, Bill Gates and the BGI Group.  Another little known web includes the CEO of 23andMe, her sister who is CEO of Youtube, and her former husband – one of the founders of Google (which owns Youtube) and president of Alphabet Inc. until 2019.

And frighteningly, work done by UW researchers here in Wisconsin could also be used for nefarious reasons.

In the video, UW researchers who in 2004 figured out how to safely and effectively get therapeutic DNA inside cells were mentioned.  But a Colonel in the People’s Liberation Army states:

“University of Wisconsin scientists have made exogenous naked DNA and injected it into the veins for easy access into muscle cells for gene therapy.  By combining this knowledge and particle-gun technology, we could create a micro bullet out of a 1 micron tungsten or gold ion, on whose surface plasmid DNA or naked DNA could be precipitated, and deliver the bullet via a gunpowder explosion, electron transmission, or a high-pressured gas to penetrate the body surface. We could then release DNA molecules to integrate with the host’s cells through blood circulation and cause disease or injury by controlling genes.

While China amasses genetic information from around the world, it has banned the collection or preservation of its citizen’s genetic information.

All of a sudden, the following article does not seem so far fetched and makes a lot of sense.

https://thevaccinereaction.org/2023/07/genetics-may-predispose-susceptibility-to-covid/

Genetics May Predispose Susceptibility to COVID

by Marco Cáceres

Published July 23, 2023

Opinion

It is generally accepted that COVID-19 (coronavirus disease 2019) is caused by an infection with the virus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). The virus enters human cells via a protein coding gene known as ACE2 (angiotensin converting enzyme 2). It is also largely accepted that COVID can affect different people in different ways, ranging from asymptomatic infection to severe disease, which can include respiratory failure and death. Some studies note, “risk factors for severe COVID-19 include male sex, older age, ethnicity, obesity and cardiovascular and respiratory diseases, among others.”1 2 3 4

Additionally, genetic factors have been shown to play a role in a person’s susceptibility to infection with SARS-CoV-2 and to developing severe symptoms of COVID.

Studies Suggest Genetic Factors Determine Reactions to COVID

Numerous studies have been undertaken to try and understand how host genetic factors can predispose someone to COVID. One study, for example, published in the journal Biochemistry and Biophysics Reports in December 2020 investigated how different “coding variants” of ACE2 among certain populations decreased or increased the SARS-CoV-2/ACE2 “electrostatic attention” or “binding energy.”2 5 6 

The authors stated:

Here, we combined ACE2 coding variants’ analysis in different populations and computational chemistry calculations to probe the effects on SARS-CoV-2/ACE2 interaction. ACE2-K26R; which is most frequent in Ashkenazi Jewish population decreased the SARS-CoV-2/ACE2 electrostatic attraction. On the contrary, ACE2-I468V, R219C, K341R, D206G, G211R increased the electrostatic attraction; ordered by binding strength from weakest to strongest. The aforementioned variants are most frequent in East Asian, South Asian, African and African American, European, European and South Asian populations, respectively.6

In another study published in the journal BMC Medicine in July 2020, researchers investigated genetic susceptibility to COVID by examining DNA polymorphisms (two or more variant forms) in ACE2 and the gene TMPRSS2 (transmembrane protease, serine 2). They identified 63 “potentially deleterious” variants in ACE2 and 68 “deleterious” variants in TMPRSS2, and they found that the “distribution of deleterious variants in ACE2” differs among nine populations. The researchers wrote:

Specifically, 39% (24/61) and 54% (33/61) of deleterious variants in ACE2 occur in African/African-American (AFR) and Non-Finnish European (EUR) populations, respectively Prevalence of deleterious variants among Latino/Admixed American (AMR), East Asian (EAS), Finnish (FIN), and South Asian (SAS) populations is 2–10%, while Amish (AI) and Ashkenazi Jewish (ASJ) populations do not appear to carry such variants in ACE2 coding regions.7

There are many other similar studies that indicate that genetic factors within different geographic and ethnic groups can play a role in the susceptibility of these populations to SARS-CoV-2 infection and the manifestation of COVID symptoms. This may explain why COVID has affected certain people disproportionately.8 9 10

Biology Can Also Determine Reactions to Other Diseases, Toxins and Vaccination

This realization, however, should come as no great surprise. After all, we are all different genetically, epigenetically. Consequently, each of us can react differently to diseases, environmental toxins and medical interventions such as vaccination.

“Each one of us is born with different genes and a unique microbiome influenced by epigenetics that affects how we respond to diseases and pharmaceutical products like vaccines,” says Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center.11

One of the best examples of how genetic variation can determine the susceptibility of a race or ethnic group to disease is sickle-cell disease, which is more common in African and Mediterranean populations than in northern European populations. The opposite is the case for the genetic disorder cystic fibrosis and the condition known as hemochromatosis (iron overload).12

According to the Susan G. Komen Foundation, the chances of a woman developing breast cancer can be determined by her ethnic background. For example, white and black women are more likely to get breast cancer than Asian/Pacific Islander or Hispanic women.13

We are biologically diverse, and that can be a strength or a weakness, depending on the threats we face. This has perhaps never been more true than with the COVID pandemic and the COVID shots.

Many people, regardless of their limited exposure to the SARS-CoV-2 virus or vaccination status, came down with COVID. On the other hand, there were many people who, despite heavy exposure to SARS-CoV-2, never got COVID. “There are numerous examples of couples in which one partner got seriously ill, and the spouse was taking care of them yet did not get infected,” said András Spaan, MD, PhD, a clinical microbiologist at the St. Giles Laboratory of Human Genetics of Infectious Diseases at New York’s Rockefeller University.14

The same can be said for the COVID shots. Approximately 81 percent of the people in the United States received at least one dose of the available COVID shots. Some 70 percent of the people in the U.S. were “fully vaccinated,” meaning at least two doses or equivalent. Many of those people experienced no noticeable short-term harm from the shots. However, many of them did and were left with Long COVID Vaccination Syndrome (LCVS) or died.15 16 17

References:

1 GeneCards. ACE2 Gene – Angiotensin Converting Enzyme 2.
2 Horowitz JE. Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nature Mar. 3, 2022.
3 National Library of Medicine. ACE2 angiotensin converting enzyme 2 [ Homo sapiens (human) ] July 16, 2023.
4 U.S. Centers for Disease Control and Prevention. COVID-19.
5 Rabaan AA. Genetic Variants and Protective Immunity against SARS-CoV-2. Genes (Basel) Dec. 13, 2022; 13(12): 2355.
6 Ali F et al. ACE2 coding variants in different populations and their potential impact on SARS-CoV-2 binding affinity Biochem Biophys Rep December 2020; 24: 100798.
7 Hou Y et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Medicine July 15, 2020.
8 Bakhshandeh B. Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol June 2021; 90: 104773.
9 Beyerstedt S. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis May 2021: 40(5): 905-919.
10 Ren W. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection. J Virol Jan. 12, 2022; 96(1): e0149221.
11 Fisher BL. Vaccine Culture War Myths. National Vaccine Information Center.
12 Jorde LB, Wooding SP. Genetic variation, classification and ‘race’. Nature Oct. 26, 2004.
13 PIH Health. Ethnicity and Disease Risk: What’s the Connection? Apr. 21, 2021.
14 Boyle P. Are some people immune to COVID-19? AAMC News Jan. 19, 2023.
15 USAFacts.org. US Coronavirus vaccine tracker.
16 The Vaccine Reaction. Risk & Failure Reports.
17 Parpia R. “Long COVID Vaccination Syndrome” and “Long COVID” Illness Are Similar. The Vaccine Reaction July 17, 2023.

________________

**Comment**

Despite this peer-reviewed research, those of you with ears to the ground heard about the “poo storm” when Robert F. Kennedy spoke of this research and was recorded at a dinner party.  He was promptly accused of being a racist conspiracy theorist at what was described as a “booze and fart-filled dinner.”

Journalists have truly lost their way.

A reasonable sequitur would be: since the injections use the same spike protein as COVID, the injections could also be potentially racially targeting.

But there’s another reason people are having different outcomes after the COVID shots:  the entire DOD program is an ongoing clinical experiment with different arms.  This simply means some people were told they got the gene therapy injection but actually got a placebo.  Others received a lower dose and other a higher dose.  However, no matter how you cut it, the shots are bad all around with 75% of deaths causally related to the shots.

But this research has been conveniently censored by The Lancet, because it too is an inconvenient truth.

A lot can be explained due to the microclotting being seen by doctors who are using D-dimer tests of “vaccinated” patients with adverse reactions. Embalmers are also finding arteries filled with clots in the “vaccinated”.  The most implicated organ system in COVID vaccine-associated death was the cardiovascular system (53 percent), followed by the hematological (blood) system (17 percent), the respiratory system (8 percent) and multiple organ systems (7 percent). The mean time from vaccination to death was 14.3 days, with most deaths occurring within a week from last administration of a shot.1

Research has also shown “vaccine” induced thrombocytopenia and thrombosis (VITT) and increased heart attacks.

This is also why aspirin and proteolytic enzymes like lumbrokinase, serrapeptase and nattokinase, (which has antiviral effects,) have been successful in helping to treat COVID as well as injuries caused by the injection.

It is high time these gene-therapy clot shots were banned. 

Category:

Activism, Treatment, vaccines, Viruses

Wrongful Death Lawsuit Against Ascension Hospital

https://www.americaoutloud.news/grace-under-pressure-a-fathers-courage-to-face-the-biopharmaceutical-complex/

Grace Under Pressure – A Father’s Courage to Face the Biopharmaceutical Complex

by  | Apr 10, 2023

It is believed that Ernest Hemingway wrote that “courage [or guts] is grace under pressure.” What an intriguing way of putting it! In so many ways, this describes the relentless pursuit of a father seeking justice for his daughter’s death.

This week’s McCullough Report features an exclusive interview with Scott Schara, father of his late daughter, Grace. Scott and his family have been fighting for justice in order to help others who are facing similar situations. Here is an excerpt from a recent press release:

“March 29, 2023, Grace Schara, a 19-year-old with Down Syndrome, died at St. Elizabeth’s Hospital (Ascension) after medical personnel administered three drugs that, when given together, are known to hasten severe hypoxia– Precedex, Lorazepam, and Morphine. As Grace slipped into acute respiratory failure and Grace’s sister begged for help, instead of starting CPR immediately, the nurses refused; Grace’s physician had independently designated her as a “Do Not Resuscitate” (DNR). That DNR order was written without the family’s consent and in defiance of the Schara family’s express wishes that all lifesaving measures be deployed for their Down Syndrome daughter. As a result of the lethal cocktail of drugs and the fraudulent DNR order Grace died on Oct. 13, 2021. The Schara family will be filing a first of its kind lawsuit against St. Elizabeth’s Hospital (Ascension), and doctors and nurses related to the wrongful death of Grace Schara. The first step in the process is a request for mediation with the Director of State Courts, which will be filed on March 30. “St. Elizabeth’s not only breached the Standard of Care, but their unethical behavior led directly to Grace’s death,” stated father, Scott Schara. “It’s clear to me that this hospital was a dangerous place for Down Syndrome patients like my daughter. My Grace was discriminated against due to her disability and she received grossly subpar healthcare, in clear violation of the Americans with Disabilities Act.” Grace’s legal case will lay the groundwork for other hospital victims where their right to informed consent was denied and the patient suffered injury and death.”

See link for article and audio interview

_________________

**Comment**

I wrote about this unfortunate case which happened right here in Wisconsin:   https://madisonarealymesupportgroup.com/2022/02/14/stay-away-from-hospitals-if-you-can/

Excerpt:

An international lawyer with Disabled Rights Advocates and legal counsel to the Truth for Health Foundation describes how if a person goes into the hospital with even a broken arm, they will be tested for COVID, which has an extremely high false-positive rate.  If they don’t test positive immediately, they keep testing until they do. Then, the patient is admitted, put on an IV bag with a tranquilizer that lowers their oxygen absorption, which then justifies putting the patient into isolation and on the anti-viral remdesivir and then given morphine and fentanyl while being deprived of nutrition.

This completely evil racket comes from the WHO on down the line:

COVID protocols are passed down hierarchically from the World Health Organization (WHO) to Centers for Disease Control (CDC) and National Institute of Health (NIH), arising from the Public Readiness and Emergency Preparedness Act (PREP Act) and Health and Human Services authorization to release funding for the declared pandemic that sets the protocols in motion.

From there, hospitals that are federally funded through Centers for Medicare and Medicaid Services (CMS) use coding tied to NIH and CDC-written protocols. If hospitals take that funding, they must follow those protocols, starting with ICD-10 codes (International Classification of Diseases).

The CDC and NIH protocols are based on the WHO’s 2005 International Health Regulations that directs each of its 196 signatory countries to cede all sovereign powers to the WHO in the case of a declared health emergency.

The WHO then directs the various state health bodies—in this case, the CDC and NIH—on treatment, which is why every country is responding in the same way at the same time globally.

When these protocols are passed down to the hospitals that take funding, under the emergency declaration, patients’ rights are waived under the CMS COVID waiver program in conjunction with the PREP and CARES Act, giving participating hospitals legal immunity.

This is a perfect moment to insert a post from a 3rd year law student’s paper advocating for a “federal” solution to Lyme.  This isn’t just a “no,” this is a “hell no!”  I repeat: putting the power into the hands of the few will follow the ‘law of unintended consequences’ and will hurt patients and doctors in the end.  COVID is a PERFECT example.  Don’t do it!

Dr. Peterson Pierre explains the reason hospitals are killing COVID patients. The information is a reiteration of the excellent article written by Dr. Vliet. In short, in vast government overreach, the government is paying hospitals to do the wrong things.  The problem is so bad, some physicians have formed a new alliance, called the Pandemic Health Alliance and have drafted a “Physicians Declaration” and released it Sept. 12 at a global Covid summit in Rome, Italy.

This is also a perfect example why the ‘Pandemic Treaty’ would only make this worse as it hands over the keys to global government and pushes for global “vaccine” passports.  Especially now as the media have already begun their next “tripledemic” narrative in lockstep, but will never, ever, in a million years explain that the reason for concern over three viruses worsening is entirely due to the “vaccinated” and the subsequent ADE or pathogenic priming setting people up for immune overload and  more severe disease.

It’s a no-brainer.

Category:

Activism, Treatment, Viruses